Related Experiment Video
Updated: Sep 18, 2025

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Transition From Intraoperative Vancomycin-Piperacillin Tazobactam to Vancomycin-Cefepime Does Not Change Acute Kidney
Ashley L Golbus1, Syed Quadri2, Elaine Park1
1College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Introduction:
The impact of empiric intraoperative vancomycin and piperacillin-tazobactam (VPT) compared to vancomycin and cefepime (VC) on AKI is equivocal, and renal recovery and infection outcomes have not been studied in this context. Further, this has not been studied in patients undergoing orthotopic heart transplantation (OHT).
Methods:
We performed a single-center prospective study in patients undergoing OHT (n = 120), with a change in intraoperative microbial coverage from VPT to VC. Primary outcomes included AKI rates and stage. Secondary outcomes included renal recovery rates, bloodstream bacterial infections, rates of enterococcal infection, ESRD (end-stage renal disease), change in eGFR, and mortality at 12 months post-OHT.
Results:
Rates of all stages of AKI were similar between groups (p = 0.769), and the majority of AKI in both groups were Stage 1. 27.1% of patients in the pre-intervention arm and 25.0% in the post-intervention arm had a Stage 3 AKI (p = 0.798). Rates of recovery from AKI at 7 days showed a trend toward improved recovery in patients receiving VC compared to VPT (65.1%, 46.7%, p = 0.056), but recovery from RRT at 7 days and recovery from RRT at hospital discharge were not statistically significant between groups (p = 0.140, p = 0.659). Rates of bloodstream infection were similar following the change in empiric antimicrobials (2.08%, 4.17%; p = 0.53), and rates of wound infection were similar following this change (4.2%, 1.4%; p = 0.56). There was no increase in enterococcal infections.
Conclusion:
In patients undergoing OHT and receiving empiric antimicrobial therapy, change from VPT to VC did not affect the incidence or severity of AKI, renal recovery, or infection rates.
Insights
Changing intraoperative antibiotics from vancomycin and piperacillin-tazobactam (VPT) to vancomycin and cefepime (VC) did not impact acute kidney injury (AKI) or infection rates in heart transplant patients. Renal recovery and other outcomes remained similar between the two antibiotic regimens.
Area of Science:
- Nephrology
- Cardiology
- Infectious Diseases
Background:
- The impact of empiric intraoperative antibiotics vancomycin and piperacillin-tazobactam (VPT) versus vancomycin and cefepime (VC) on acute kidney injury (AKI) is unclear.
- Renal recovery and infection outcomes in this context, particularly after orthotopic heart transplantation (OHT), require further investigation.
Purpose of the Study:
- To evaluate the effect of switching intraoperative antimicrobial coverage from VPT to VC on AKI rates and severity in OHT patients.
- To assess secondary outcomes including renal recovery, bloodstream infections, enterococcal infections, end-stage renal disease (ESRD), eGFR changes, and mortality.
Main Methods:
- A single-center prospective study involving 120 patients undergoing OHT.
- Patients received either VPT or VC for intraoperative microbial coverage, with a switch from VPT to VC during the study period.
- Primary outcomes were AKI rates and stage; secondary outcomes included renal recovery, infection rates, and mortality.
Main Results:
- No significant difference in AKI rates or severity was observed between the VPT and VC groups (p = 0.769).
- The majority of AKI cases were Stage 1, with similar rates of Stage 3 AKI between groups (27.1% vs. 25.0%, p = 0.798).
- Rates of bloodstream infections (2.08% vs. 4.17%, p = 0.53) and wound infections (4.2% vs. 1.4%, p = 0.56) were similar, with no increase in enterococcal infections.
Conclusions:
- Switching empiric intraoperative antimicrobial therapy from VPT to VC in OHT patients did not alter the incidence or severity of AKI.
- The change in antibiotic regimen did not significantly affect renal recovery rates or infection outcomes.
- VC can be considered a safe alternative to VPT in OHT patients regarding renal and infectious complications.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant I: Introduction
Acute Kidney Injury I: Introduction
Kidney Transplant III: Nursing Management
Acute Kidney Injury II: Pathophysiology

